MicroStockProfit.com announces an investment report featuring K-V Pharmaceutical Co. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
K-V Pharmaceutical Co. (KV-A) is a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technologically-distinguished branded and generic/non-branded prescription pharmaceutical products. Its strategic goal is to become a specialty branded pharmaceutical marketing company primarily focused on women's healthcare. The Company conducts its branded pharmaceutical operations through Ther-Rx and, previously, it conducted its generic/non-branded pharmaceutical operations through ETHEX, which focused principally on technologically-distinguished generic products. In May 2010, the Company formed a wholly-owned subsidiary, Nesher, to operate as the sales and marketing company for its generic products. The Company expects to complete a divestiture of Nesher and the Company's generics business by the end of calendar year 2011.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment